Back

Evaluating the Effectiveness of International Travel Controls to Identify Monkeypox Virus Infected Travelers

Ejima, K.; Wang, Y.; Endo, A.; Murayama, H.; Goh, Y. S.; Cook, A. R.; Jeong, Y. D.; Iwami, S.; Park, H.; Dickens, B.; Jin, S.; Lim, J. T.; Chan, C.; Chia, P. Y.; Young, B.; Yang, Y.; Chio, M.; Lye, D.; Ajelli, M.

2025-01-10 infectious diseases
10.1101/2025.01.10.25320302 medRxiv
Show abstract

IntroductionIn August 2024, the World Health Organization (WHO) declared a public health emergency due to the rapid spread of mpox in African and beyond. International travel controls (ITCs), such as health screening and viral testing, could help avoid/delay the global spread of the monkeypox virus (MPXV), fostering preparedness and response efforts. However, it is not clear whether the viral tests at immigration are sufficient to avoid importation of MPXV and which samples should be used on the viral tests. MethodsWe conducted a simulation study using epidemiological and viral load data to assess the effectiveness of health screening and PCR testing at immigration. This provides estimates of the proportion of infected travelers identified with this policy. Viral dynamics models were used to estimate false-negative rates of PCR tests with different detection limits according to testing regimens at three different sites: oropharynx, saliva, and rectum. We also simulated the effects of these border control methods on the recommended duration of a monitoring period for travelers from mpox-affected regions, during which individuals would self-monitor for symptoms and practice cautionary behavior. ResultsOur results show that the combination of health screening and PCR testing of saliva swabs under an endemic scenario identify only 74% of MPXV infected travelers. The use of rectal swabs combined with health screening allows the identification of a marginally larger share of infected travelers (79%) compared to saliva swabs. A similar identification rate could be achieved by using more sensitive PCR tests (detection limit [DL]: 10 copies/mL vs. 250 copies/mL used in our baseline analysis). We estimated that travelers from mpox-affected areas should monitor themselves and practice precautionary behavior for 16 days. ConclusionHealth screening and PCR testing at immigration are likely to miss a significant proportion of MPXV-infected travelers, thus a lengthy quarantine period would be required to prevent onward local transmission. Careful consideration on other factors such as economic costs and likelihood of widespread local outbreak will need to be weighed against the adoption of these measures to prevent local mpox transmission given MPXV transmissibility and severity.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS Neglected Tropical Diseases
378 papers in training set
Top 0.5%
22.3%
2
Journal of Travel Medicine
18 papers in training set
Top 0.1%
8.3%
3
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.1%
6.3%
4
Emerging Infectious Diseases
103 papers in training set
Top 0.4%
4.3%
5
PLOS ONE
4510 papers in training set
Top 36%
3.9%
6
One Health
29 papers in training set
Top 0.2%
3.9%
7
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 1%
3.9%
50% of probability mass above
8
BMC Infectious Diseases
118 papers in training set
Top 0.9%
3.8%
9
Clinical Infectious Diseases
231 papers in training set
Top 2%
3.6%
10
Eurosurveillance
80 papers in training set
Top 0.5%
2.1%
11
The Lancet Microbe
43 papers in training set
Top 0.5%
1.9%
12
International Journal of Infectious Diseases
126 papers in training set
Top 1%
1.9%
13
BMC Medicine
163 papers in training set
Top 4%
1.7%
14
Viruses
318 papers in training set
Top 3%
1.7%
15
Tropical Medicine and Infectious Disease
12 papers in training set
Top 0.1%
1.7%
16
Infectious Disease Modelling
50 papers in training set
Top 0.8%
1.6%
17
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.3%
1.5%
18
Scientific Reports
3102 papers in training set
Top 64%
1.3%
19
Journal of Medical Virology
137 papers in training set
Top 3%
1.2%
20
Journal of Medical Entomology
17 papers in training set
Top 0.4%
1.1%
21
The Lancet Infectious Diseases
71 papers in training set
Top 3%
0.9%
22
Pathogens
53 papers in training set
Top 1%
0.9%
23
BMC Public Health
147 papers in training set
Top 5%
0.9%
24
Nature Communications
4913 papers in training set
Top 61%
0.8%
25
PeerJ
261 papers in training set
Top 15%
0.7%
26
Epidemics
104 papers in training set
Top 2%
0.7%
27
PLOS Global Public Health
293 papers in training set
Top 6%
0.7%
28
Epidemiology and Infection
84 papers in training set
Top 3%
0.7%
29
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.6%
30
Journal of Infection
71 papers in training set
Top 3%
0.6%